Listen to this article · 9 min listen

A shocking 72% of medical device companies are planning to pour a lot more money into R&D over the next three years, which just highlights the intense pressure to innovate in healthcare and makes your expo prep more important than ever.

Key Takeaways

  • With over 70% of med device firms ramping up R&D, you can expect an expo floor that’s packed with serious competition and real innovation.
  • Digital health, especially AI diagnostics, is going to be everywhere in new product launches, so you better be ready to show how your tech handles and integrates data.
  • Supply chain stability and making things locally are huge talking points, with 65% of companies building their 2026 strategies around them.
  • Getting new devices (especially AI ones) through regulatory is a minefield, so you need to be upfront at your booth about how you’re dealing with changing FDA and EMA rules.
72%
R&D Spending Surge
Med device companies anticipate significant R&D increase over 3 years.
60%+
New Devices are Digital
Newly launched medical devices incorporate digital health components.
65%
Supply Chain Priority
Companies prioritize resilience and localized manufacturing for 2026.

The 72% Surge in R&D: What it Means for Your Expo Strategy

That 72% R&D spending increase reported in the recent Deloitte MedTech outlook for 2026 isn’t just an interesting number. It’s a complete reset of the competitive field for any medical device expo. We’re seeing more products, yes, but they’re also bringing a much higher level of sophistication and specialization. For exhibitors, this means the old baseline for what counts as “new” is gone. The competition isn’t just about functionality anymore. It’s about the depth of your scientific backing, the novelty of your core technology, and the clinical impact you can actually prove. I’ve seen this firsthand prepping clients for these shows: the days of just showing up with a slightly better version of last year’s model are over. Attendees, especially the investors and big-system buyers, are hunting for breakthroughs. They want to see how your device solves a real clinical problem that current tools can’t touch. This means your story has to dig deep into the research, the clinical trial data, and your long-term vision. Showing up with a device that only offers a small improvement in a crowded field is a surefire way to get ignored. You have to nail the “why” behind your work and explain what makes it special in a sea of new R&D money.

Digital Health Integration: Over 60% of New Devices

A late 2025 report from the Medical Device Manufacturers Association (MDMA) is telling: over 60% of new devices being launched have major digital health features, from AI diagnostics to remote monitoring. This shows a deep shift from a few years ago when digital was often an afterthought. It’s now foundational. For any company exhibiting at a medical device expo, failing to emphasize your device’s digital connections is a huge mistake. It’s about more than just having an app. It’s about proving your device slides right into a hospital’s IT setup, spits out useful data, and actually improves patient outcomes because it’s connected. Think about AI in diagnostic imaging. A new ultrasound machine might have amazing image clarity, but if it can’t work with an AI algorithm that automatically flags anomalies, its value drops fast. Exhibitors have to demonstrate the whole digital workflow, not just the physical tool. This could mean live demos showing data flowing into an electronic health record (EHR), walking people through the data analysis dashboard, or presenting case studies with hard numbers on improved diagnostic speed. The conversation at your booth has to go beyond the hardware and get into the smart software and connectivity that define a modern medical device.

Supply Chain Resilience: A Top Priority for 65% of Companies

The chaos of the past few years permanently scarred the medical device industry. A recent McKinsey & Company analysis found that 65% of companies now call supply chain resilience a top strategic priority for 2026. This focus is about demonstrating reliability and ethical sourcing, two things that purchasers and regulators care about more and more. At an expo, people aren’t just looking at your product. They’re judging the stability of your whole operation. So what does that mean for your presentation? You have to be ready to talk about your supply chain with total transparency. Highlight your diversified sourcing, any moves toward local manufacturing, or your inventory management systems. For instance, if you source key components from multiple suppliers across different continents, make that clear. If you just spent a fortune on a new manufacturing plant in Georgia to be less dependent on overseas factories, that’s a massive selling point. It might not be the sexiest part of your pitch, but for buyers who hate risk, it’s essential. Having a clear, one-page summary of your supply chain plan can build a ton of confidence and set you apart from competitors who look unprepared for the next global hiccup.

Regulatory Adaptability: 80% of Firms Facing New Compliance Challenges

A MedComply Solutions report just confirmed that 80% of medical device firms expect to hit new or tougher regulatory challenges in the next two years, especially around software as a medical device (SaMD) and AI. That number is everything because regulatory approval is the only gate to the market. At an expo, even with all the talk of new tech, the worry about compliance is always humming in the background for any serious buyer or partner. Some people will tell you to leave the regulatory talk to the lawyers behind closed doors. I think that’s terrible advice. For a novel device, especially one with new AI or connectivity features, being proactive and open about your regulatory plan at the expo is critical. You don’t have to drown attendees in legalese. Just clearly explain your path to market, your compliance with key standards (like IEC 62304 for software or ISO 13485 for quality management), and how you’re working with bodies like the FDA in the US or the EMA in Europe. Having an expert at the booth who can speak confidently about this stuff is a huge advantage. It shows you’re mature and thinking ahead, reassuring partners that your cool new device is actually a viable and compliant business. This kind of prep builds confidence that you get the regulatory game, a detail that’s often ignored until it’s too late.

Cybersecurity Threats: Doubling of Incidents in 2025

The Healthcare Cybersecurity Alliance’s annual report confirmed what we all felt: cyberattacks on medical devices and patient data doubled in 2025. This disturbing trend improves cybersecurity from a back-office IT problem to a core issue of patient safety and business survival. At a medical device expo, you absolutely cannot treat cybersecurity as an add-on. It has to be part of your product’s core value. While you might think talking about security risks could scare people off, in 2026, the opposite is true. Buyers are painfully aware of these threats. Showing that you have a strong, proactive security plan, from how the device is built to how it handles data, is how you build trust. Be ready to talk about your encryption protocols, secure boot mechanisms, your patching strategy, and how the device fits into a secure hospital network. Have your certifications or penetration test summaries ready (the non-sensitive parts, of course). The conversation needs to focus on how your device is built to minimize risk and contain damage. For any serious medical device today, that kind of security transparency is non-negotiable. Preparing for a medical device expo in 2026 takes a lot more than a shiny new piece of hardware. You need a complete presentation that weaves together the realities of digital integration, supply chain stability, regulatory foresight, and tough cybersecurity. Focusing on these areas is how you’ll actually get noticed. Proper career development for these big events depends on getting these details right. This preparation builds confidence that you understand the complex field you’re in, which is something people often forget until there’s a problem. For professionals wanting to get ahead, knowing how to build your executive polish and confidence is a huge part of this. Being transparent about your security measures is simply what’s expected now. Don’t be one of the 72% unprepared: Career prep fails in 2026. Do the strategic work.

What’s the #1 thing to highlight at a med device expo in 2026?

The most important thing is proving your device fits into the bigger digital health world. You have to show its data capabilities and how its connectivity leads to better clinical workflows or patient outcomes.

How important is talking about our supply chain at an expo?

It’s incredibly important. With 65% of companies making resilience a priority, you need to be ready to discuss your diversified sourcing, any local manufacturing, and inventory plans to make buyers feel confident.

Should we really discuss regulatory compliance at our booth?

Yes, absolutely. For new devices, being open and clear about your regulatory plan, your standards, and your talks with agencies like the FDA or EMA is key to making potential partners feel secure.

What’s cybersecurity’s role when showing a new device?

Cybersecurity is a patient safety issue, period. You have to build it into your sales pitch. Be prepared to talk about encryption, secure boot, patching, and how your device is designed to minimize and handle threats.

What data should we have ready for our digital health features?

You should be ready to show how the device talks to EHRs, demonstrate the user dashboards for data analysis, and present case studies with actual numbers on improved diagnostic accuracy or a lighter clinician workload.